Tracking Replicating HPV Genomes in Proliferating Keratinocytes
This paper developed a live-cell molecular tool to monitor replication and segregation of HPV18 genomes in keratinocytes by inserting the ANCHOR cis element into the HPV18 late region and expressing ParB-GFP from an HPV18-dependent replicon. The authors report that the resulting small replicon, containing the HPV18 replication origin and viral transcriptional enhancer, can replicate stably in keratinocytes when complemented by the HPV18 genome and minimally triggers innate immune activation, with neomycin resistance used for selection. Using fluorescent detection, they visualized partitioning in dividing cells and found HPV18-ANCH3 genomes were distributed somewhat equally to daughter cells, consistent with random attachment to host chromosomes. The study’s key limitation is that it tracks indirect fluorescent signals from an engineered replicon/ANCH3 system rather than native full viral genome dynamics. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Full text
1,850 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
References (36)
- doi:10.1128/9781555818982.ch8 via crossref
- doi:10.1098/rsob.200097 via crossref
- doi:10.1038/sj.emboj.7601853 via crossref
- doi:10.1083/jcb.201702013 via crossref
- doi:10.1016/j.tvr.2024.200291 via crossref
- doi:10.1128/jvi.72.3.2079-2088.1998 via crossref
- doi:10.1128/jvi.73.5.4404-4412.1999 via crossref
- doi:10.1146/annurev-virology-092818-015716 via crossref
- doi:10.1128/jvi.00686-21 via crossref
- doi:10.1073/pnas.0507624103 via crossref
- doi:10.1128/jvi.80.9.4431-4439.2006 via crossref
- doi:10.1128/jvi.01879-22 via crossref
- doi:10.1128/jvi.02170-17 via crossref
- doi:10.1016/0168-1656(87)90049-6 via crossref
- doi:10.1128/mbio.01758-17 via crossref
- doi:10.1016/j.bpj.2017.08.014 via crossref
- doi:10.1038/s41586-021-04228-1 via crossref
- doi:10.1172/jci42297 via crossref
- doi:10.1038/srep37782 via crossref
- doi:10.1128/spectrum.01601-21 via crossref
- doi:10.3791/4305:e4305 via crossref
- doi:10.1016/j.jviromet.2021.114194 via crossref
- doi:10.3390/biomedicines8120543 via crossref
- doi:10.3390/v12010050 via crossref
- doi:10.1128/jvi.00795-18 via crossref
- doi:10.1128/jvi.00571-18 via crossref
- doi:10.1016/0092-8674(87)90662-3 via crossref
- doi:10.1128/jvi.66.12.6946-6952.1992 via crossref
- doi:10.1038/s41467-023-40320-y via crossref
- doi:10.1016/b978-0-12-814457-2.00004-0 via crossref
- doi:10.1002/j.1460-2075.1984.tb01944.x via crossref
- doi:10.1128/mbio.01644-16 via crossref
- doi:10.1038/nmeth.2019 via crossref
- doi:10.5962/bhl.title.168645 via crossref
- doi:10.1126/science.2443981 via crossref
- doi:10.2307/2331554 via crossref
Source provenance
- crossref
- last seen: 2026-06-30T06:26:27.925341+00:00
- europepmc
- last seen: 2026-05-20T01:45:00.602351+00:00
- unpaywall
- last seen: 2026-05-22T02:00:06.705733+00:00